| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transplantation, Heterologous | 191 | 2024 | 2385 | 9.410 |
Why?
|
| Swine, Miniature | 255 | 2021 | 961 | 8.900 |
Why?
|
| Transplantation Tolerance | 75 | 2022 | 605 | 8.600 |
Why?
|
| Immune Tolerance | 168 | 2021 | 2303 | 7.420 |
Why?
|
| Kidney Transplantation | 183 | 2024 | 4234 | 7.200 |
Why?
|
| Transplantation Chimera | 80 | 2022 | 594 | 7.140 |
Why?
|
| Swine | 427 | 2022 | 5915 | 7.040 |
Why?
|
| Bone Marrow Transplantation | 149 | 2022 | 2693 | 6.290 |
Why?
|
| Graft Survival | 172 | 2024 | 3819 | 6.170 |
Why?
|
| Graft Rejection | 185 | 2022 | 4445 | 5.490 |
Why?
|
| Skin Transplantation | 97 | 2018 | 1083 | 4.470 |
Why?
|
| Thymus Gland | 87 | 2016 | 1243 | 4.000 |
Why?
|
| Galactosyltransferases | 38 | 2020 | 276 | 3.690 |
Why?
|
| Papio | 102 | 2021 | 669 | 3.500 |
Why?
|
| Major Histocompatibility Complex | 95 | 2021 | 870 | 3.470 |
Why?
|
| Transplantation Immunology | 46 | 2015 | 532 | 3.160 |
Why?
|
| Transplantation, Homologous | 174 | 2019 | 4806 | 3.140 |
Why?
|
| Organ Transplantation | 31 | 2022 | 1157 | 2.850 |
Why?
|
| Histocompatibility Antigens Class II | 72 | 2015 | 1435 | 2.690 |
Why?
|
| Histocompatibility Antigens Class I | 54 | 2014 | 1349 | 2.680 |
Why?
|
| T-Lymphocytes | 166 | 2020 | 10194 | 2.530 |
Why?
|
| Cyclosporine | 58 | 2018 | 778 | 2.430 |
Why?
|
| Chimerism | 16 | 2022 | 155 | 2.360 |
Why?
|
| Lymphocyte Depletion | 58 | 2019 | 602 | 2.210 |
Why?
|
| H-2 Antigens | 63 | 2002 | 357 | 2.140 |
Why?
|
| Heart Transplantation | 55 | 2022 | 3233 | 2.070 |
Why?
|
| Histocompatibility Antigens | 69 | 2015 | 464 | 2.050 |
Why?
|
| Isoantigens | 45 | 2015 | 551 | 2.010 |
Why?
|
| Animals | 771 | 2024 | 168459 | 1.980 |
Why?
|
| Histocompatibility Testing | 57 | 2019 | 712 | 1.920 |
Why?
|
| Islets of Langerhans Transplantation | 14 | 2017 | 740 | 1.850 |
Why?
|
| Immunosuppressive Agents | 84 | 2021 | 4174 | 1.750 |
Why?
|
| Isoantibodies | 52 | 2021 | 674 | 1.660 |
Why?
|
| Histocompatibility | 31 | 2021 | 317 | 1.610 |
Why?
|
| Immunotoxins | 16 | 2018 | 175 | 1.610 |
Why?
|
| Transplants | 4 | 2022 | 206 | 1.600 |
Why?
|
| Chimera | 32 | 2001 | 453 | 1.500 |
Why?
|
| Transplantation Conditioning | 46 | 2022 | 1590 | 1.490 |
Why?
|
| Genes, MHC Class II | 41 | 2003 | 434 | 1.480 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 49 | 2022 | 5671 | 1.440 |
Why?
|
| Animals, Genetically Modified | 39 | 2021 | 1561 | 1.390 |
Why?
|
| Diphtheria Toxin | 14 | 2018 | 253 | 1.370 |
Why?
|
| Cytotoxicity, Immunologic | 48 | 2001 | 1351 | 1.340 |
Why?
|
| Antibodies, Monoclonal | 112 | 2019 | 9177 | 1.310 |
Why?
|
| Disaccharides | 20 | 2004 | 170 | 1.310 |
Why?
|
| Immunoglobulin Idiotypes | 30 | 1989 | 200 | 1.310 |
Why?
|
| Lymphocyte Culture Test, Mixed | 63 | 2015 | 509 | 1.280 |
Why?
|
| Epitopes | 75 | 2011 | 2503 | 1.270 |
Why?
|
| Tissue Donors | 32 | 2022 | 2331 | 1.210 |
Why?
|
| Antibodies, Heterophile | 17 | 2015 | 128 | 1.200 |
Why?
|
| Transplantation | 10 | 2013 | 219 | 1.160 |
Why?
|
| Allergy and Immunology | 3 | 2015 | 176 | 1.030 |
Why?
|
| Lung Transplantation | 21 | 2019 | 1310 | 1.030 |
Why?
|
| HLA Antigens | 20 | 2021 | 1328 | 1.000 |
Why?
|
| Macaca fascicularis | 42 | 2018 | 903 | 0.980 |
Why?
|
| Bone Marrow Cells | 35 | 2015 | 2416 | 0.930 |
Why?
|
| Papio hamadryas | 9 | 2018 | 31 | 0.930 |
Why?
|
| Graft vs Host Disease | 37 | 2016 | 3029 | 0.920 |
Why?
|
| Thymectomy | 25 | 2011 | 195 | 0.890 |
Why?
|
| Bone Marrow | 35 | 2019 | 2911 | 0.890 |
Why?
|
| Radiation Chimera | 22 | 2011 | 216 | 0.870 |
Why?
|
| Interleukin-2 | 19 | 2017 | 1889 | 0.870 |
Why?
|
| Kidney Failure, Chronic | 13 | 2024 | 2471 | 0.850 |
Why?
|
| Models, Animal | 28 | 2017 | 2112 | 0.820 |
Why?
|
| Immunity, Cellular | 30 | 2014 | 1560 | 0.810 |
Why?
|
| Antibodies, Anti-Idiotypic | 18 | 2016 | 357 | 0.810 |
Why?
|
| Micrococcal Nuclease | 21 | 1987 | 36 | 0.800 |
Why?
|
| Tissue and Organ Procurement | 3 | 2022 | 961 | 0.800 |
Why?
|
| Whole-Body Irradiation | 37 | 2016 | 433 | 0.790 |
Why?
|
| Mice, Inbred Strains | 68 | 2005 | 1762 | 0.770 |
Why?
|
| Antibodies | 32 | 2012 | 2418 | 0.760 |
Why?
|
| Lymphocytes | 39 | 2019 | 2612 | 0.760 |
Why?
|
| Influenza A virus | 7 | 2019 | 458 | 0.710 |
Why?
|
| Antibody Formation | 54 | 2008 | 1395 | 0.700 |
Why?
|
| Antilymphocyte Serum | 21 | 2015 | 487 | 0.700 |
Why?
|
| Flow Cytometry | 73 | 2015 | 5869 | 0.690 |
Why?
|
| Primates | 14 | 2022 | 523 | 0.670 |
Why?
|
| B-Lymphocytes | 42 | 2019 | 4758 | 0.660 |
Why?
|
| Hematopoietic Stem Cells | 33 | 2019 | 3396 | 0.640 |
Why?
|
| Immunoglobulin M | 28 | 2017 | 1527 | 0.640 |
Why?
|
| Mice | 293 | 2024 | 81525 | 0.630 |
Why?
|
| Islets of Langerhans | 7 | 2016 | 1341 | 0.620 |
Why?
|
| T-Lymphocytes, Regulatory | 23 | 2018 | 3080 | 0.610 |
Why?
|
| Immunoglobulin G | 35 | 2020 | 4544 | 0.600 |
Why?
|
| Species Specificity | 44 | 2015 | 2414 | 0.600 |
Why?
|
| Cross Reactions | 37 | 2016 | 817 | 0.590 |
Why?
|
| Disease Models, Animal | 32 | 2021 | 18252 | 0.580 |
Why?
|
| Antibody Specificity | 44 | 2017 | 1060 | 0.580 |
Why?
|
| Liver Transplantation | 16 | 2018 | 2330 | 0.570 |
Why?
|
| Tissue Preservation | 2 | 2017 | 174 | 0.570 |
Why?
|
| Skin | 17 | 2024 | 4484 | 0.560 |
Why?
|
| Kidney | 38 | 2020 | 7048 | 0.550 |
Why?
|
| Gene Knockout Techniques | 12 | 2019 | 802 | 0.540 |
Why?
|
| Hyperglycemia | 3 | 2017 | 1376 | 0.530 |
Why?
|
| Antigen-Presenting Cells | 13 | 2016 | 964 | 0.530 |
Why?
|
| Lymphocyte Activation | 39 | 2020 | 5486 | 0.530 |
Why?
|
| Adoptive Transfer | 4 | 2015 | 819 | 0.530 |
Why?
|
| Virus Replication | 13 | 2021 | 2435 | 0.510 |
Why?
|
| Receptors, Antigen, T-Cell | 14 | 2011 | 2547 | 0.500 |
Why?
|
| T-Lymphocytes, Cytotoxic | 26 | 2008 | 1784 | 0.490 |
Why?
|
| Burns | 5 | 2017 | 1882 | 0.490 |
Why?
|
| Stem Cell Factor | 12 | 2010 | 195 | 0.480 |
Why?
|
| Interleukin-3 | 14 | 2011 | 425 | 0.480 |
Why?
|
| Awards and Prizes | 2 | 2015 | 360 | 0.470 |
Why?
|
| Antigens, Heterophile | 8 | 2015 | 70 | 0.470 |
Why?
|
| Antigens, Surface | 22 | 2001 | 1606 | 0.470 |
Why?
|
| Killer Cells, Natural | 20 | 2019 | 2200 | 0.470 |
Why?
|
| CD40 Ligand | 17 | 2018 | 522 | 0.460 |
Why?
|
| Immunologic Memory | 13 | 2017 | 1359 | 0.460 |
Why?
|
| Memory | 1 | 2024 | 2188 | 0.460 |
Why?
|
| Spleen | 45 | 2007 | 2295 | 0.460 |
Why?
|
| Retroviridae | 24 | 2008 | 850 | 0.450 |
Why?
|
| Haplotypes | 22 | 2012 | 2713 | 0.450 |
Why?
|
| Lymphocyte Transfusion | 8 | 2016 | 232 | 0.440 |
Why?
|
| Gene Transfer Techniques | 11 | 2001 | 1206 | 0.440 |
Why?
|
| Receptors, CCR4 | 4 | 2018 | 77 | 0.440 |
Why?
|
| Cytotoxicity Tests, Immunologic | 41 | 2009 | 321 | 0.440 |
Why?
|
| Blood Component Removal | 4 | 2018 | 132 | 0.430 |
Why?
|
| Pharmacies | 1 | 2015 | 169 | 0.430 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 17 | 1998 | 899 | 0.430 |
Why?
|
| Antigens | 17 | 2010 | 1443 | 0.420 |
Why?
|
| Lymphoproliferative Disorders | 7 | 2015 | 531 | 0.420 |
Why?
|
| Cytomegalovirus Infections | 6 | 2014 | 831 | 0.420 |
Why?
|
| Nuclear Transfer Techniques | 3 | 2013 | 61 | 0.410 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 5 | 2017 | 263 | 0.410 |
Why?
|
| Cell Transplantation | 5 | 2017 | 472 | 0.410 |
Why?
|
| Lymphopoiesis | 2 | 2011 | 133 | 0.400 |
Why?
|
| Humans | 255 | 2024 | 761504 | 0.400 |
Why?
|
| Kidney Diseases | 6 | 2018 | 2091 | 0.400 |
Why?
|
| Genes | 24 | 1990 | 1823 | 0.400 |
Why?
|
| Heart | 4 | 2022 | 4404 | 0.390 |
Why?
|
| Host-Pathogen Interactions | 7 | 2021 | 1459 | 0.380 |
Why?
|
| Cytokines | 20 | 2021 | 7396 | 0.380 |
Why?
|
| Graft vs Host Reaction | 9 | 2001 | 102 | 0.370 |
Why?
|
| Orthomyxoviridae Infections | 4 | 2019 | 254 | 0.370 |
Why?
|
| HLA-DR Antigens | 7 | 2000 | 602 | 0.370 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 5 | 2017 | 306 | 0.360 |
Why?
|
| Waiting Lists | 2 | 2024 | 765 | 0.350 |
Why?
|
| Time Factors | 69 | 2017 | 39967 | 0.350 |
Why?
|
| Transplantation, Autologous | 14 | 2015 | 2115 | 0.350 |
Why?
|
| Immunomodulation | 1 | 2014 | 549 | 0.350 |
Why?
|
| Pichia | 7 | 2017 | 49 | 0.340 |
Why?
|
| Commerce | 1 | 2015 | 606 | 0.340 |
Why?
|
| Speech | 1 | 2015 | 554 | 0.340 |
Why?
|
| Swine Diseases | 5 | 2015 | 61 | 0.340 |
Why?
|
| Extrachromosomal Inheritance | 1 | 2009 | 18 | 0.340 |
Why?
|
| Leukocytes | 9 | 2020 | 2026 | 0.330 |
Why?
|
| Cytomegalovirus | 8 | 2018 | 756 | 0.330 |
Why?
|
| Mice, Inbred BALB C | 58 | 2015 | 6216 | 0.330 |
Why?
|
| History, 20th Century | 7 | 2015 | 2767 | 0.330 |
Why?
|
| Blood Coagulation Factors | 6 | 2017 | 365 | 0.330 |
Why?
|
| Fetal Tissue Transplantation | 6 | 2007 | 138 | 0.320 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 9 | 2012 | 225 | 0.320 |
Why?
|
| Immune Sera | 37 | 1989 | 606 | 0.320 |
Why?
|
| Leukocytes, Mononuclear | 13 | 2020 | 1844 | 0.310 |
Why?
|
| Mice, Inbred C3H | 29 | 1999 | 915 | 0.310 |
Why?
|
| Coculture Techniques | 9 | 2019 | 1341 | 0.310 |
Why?
|
| Stem Cells | 6 | 2014 | 3522 | 0.310 |
Why?
|
| Cells, Cultured | 42 | 2020 | 18965 | 0.310 |
Why?
|
| Tacrolimus | 10 | 2018 | 733 | 0.300 |
Why?
|
| Retinal Diseases | 1 | 2014 | 705 | 0.300 |
Why?
|
| RNA Viruses | 2 | 2020 | 111 | 0.290 |
Why?
|
| Genetic Engineering | 7 | 2017 | 933 | 0.290 |
Why?
|
| Chromosome Mapping | 32 | 1999 | 4615 | 0.290 |
Why?
|
| Genetic Linkage | 25 | 1989 | 2341 | 0.290 |
Why?
|
| Mice, Inbred A | 31 | 1997 | 246 | 0.290 |
Why?
|
| Trisaccharides | 4 | 2009 | 50 | 0.290 |
Why?
|
| Recombinant Proteins | 23 | 2017 | 6534 | 0.280 |
Why?
|
| Genome, Viral | 4 | 2020 | 667 | 0.280 |
Why?
|
| Leukemia, Experimental | 6 | 1990 | 225 | 0.280 |
Why?
|
| Viral Nonstructural Proteins | 3 | 2019 | 227 | 0.280 |
Why?
|
| Base Sequence | 26 | 2015 | 12441 | 0.280 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2011 | 1119 | 0.280 |
Why?
|
| Mutagenesis, Insertional | 3 | 2020 | 656 | 0.280 |
Why?
|
| Molecular Sequence Data | 32 | 2015 | 17635 | 0.280 |
Why?
|
| Genes, MHC Class I | 8 | 2002 | 235 | 0.270 |
Why?
|
| Patents as Topic | 1 | 2008 | 111 | 0.270 |
Why?
|
| Rabbits | 25 | 2013 | 4772 | 0.270 |
Why?
|
| Sus scrofa | 9 | 2017 | 428 | 0.270 |
Why?
|
| Hematopoiesis | 14 | 2019 | 2049 | 0.270 |
Why?
|
| Crosses, Genetic | 16 | 1993 | 749 | 0.270 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2018 | 3734 | 0.270 |
Why?
|
| Transfection | 25 | 2015 | 5774 | 0.270 |
Why?
|
| Immunization | 20 | 2012 | 1228 | 0.270 |
Why?
|
| Mice, SCID | 19 | 2017 | 2626 | 0.270 |
Why?
|
| Genetic Techniques | 1 | 2009 | 427 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 79 | 2024 | 22169 | 0.260 |
Why?
|
| HLA-DQ Antigens | 7 | 2003 | 191 | 0.260 |
Why?
|
| Gene Deletion | 5 | 2006 | 2665 | 0.260 |
Why?
|
| Immunity, Humoral | 5 | 2015 | 606 | 0.260 |
Why?
|
| Antigens, CD | 17 | 2007 | 4003 | 0.260 |
Why?
|
| Immunoconjugates | 6 | 2017 | 954 | 0.260 |
Why?
|
| History, 21st Century | 4 | 2015 | 1567 | 0.250 |
Why?
|
| Galectin 3 | 2 | 2018 | 240 | 0.250 |
Why?
|
| Immunity, Innate | 15 | 2021 | 3065 | 0.250 |
Why?
|
| Hematologic Neoplasms | 9 | 2019 | 1896 | 0.250 |
Why?
|
| Antigen-Antibody Reactions | 24 | 1998 | 340 | 0.250 |
Why?
|
| Splenectomy | 15 | 2010 | 391 | 0.250 |
Why?
|
| DNA Transposable Elements | 2 | 2020 | 755 | 0.250 |
Why?
|
| Binding Sites, Antibody | 22 | 1998 | 337 | 0.240 |
Why?
|
| Pancreatectomy | 6 | 2017 | 811 | 0.240 |
Why?
|
| Endogenous Retroviruses | 3 | 2018 | 111 | 0.240 |
Why?
|
| Haploidy | 12 | 2003 | 126 | 0.240 |
Why?
|
| Receptors, Interleukin-2 | 5 | 2003 | 562 | 0.240 |
Why?
|
| Podocytes | 2 | 2019 | 405 | 0.240 |
Why?
|
| Hindlimb | 4 | 2004 | 513 | 0.240 |
Why?
|
| Host-Parasite Interactions | 2 | 2017 | 300 | 0.230 |
Why?
|
| Sindbis Virus | 2 | 2014 | 36 | 0.230 |
Why?
|
| Tissue Transplantation | 4 | 2013 | 128 | 0.230 |
Why?
|
| Cryopreservation | 3 | 2017 | 728 | 0.230 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 7 | 2001 | 303 | 0.230 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 865 | 0.230 |
Why?
|
| Recombination, Genetic | 18 | 2014 | 1519 | 0.220 |
Why?
|
| Ribonuclease III | 2 | 2017 | 279 | 0.220 |
Why?
|
| Foundations | 1 | 2024 | 95 | 0.220 |
Why?
|
| Chromatography, Affinity | 9 | 2000 | 532 | 0.220 |
Why?
|
| Tissue Engineering | 3 | 2019 | 1868 | 0.220 |
Why?
|
| Genetic Vectors | 20 | 2003 | 3395 | 0.220 |
Why?
|
| Cell Separation | 17 | 2017 | 1720 | 0.220 |
Why?
|
| Interferons | 3 | 2020 | 706 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2013 | 3415 | 0.220 |
Why?
|
| Wound Healing | 5 | 2018 | 2805 | 0.220 |
Why?
|
| Gammaherpesvirinae | 4 | 2005 | 27 | 0.220 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 976 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 19 | 2008 | 4369 | 0.210 |
Why?
|
| Graft Enhancement, Immunologic | 4 | 2000 | 57 | 0.210 |
Why?
|
| Leukapheresis | 10 | 2012 | 134 | 0.210 |
Why?
|
| Killer Cells, Lymphokine-Activated | 4 | 2007 | 42 | 0.210 |
Why?
|
| Biomedical Research | 3 | 2015 | 3429 | 0.210 |
Why?
|
| Animals, Newborn | 10 | 2024 | 2678 | 0.200 |
Why?
|
| Male | 143 | 2019 | 360804 | 0.200 |
Why?
|
| Peptides | 13 | 2017 | 4358 | 0.200 |
Why?
|
| PPAR delta | 1 | 2022 | 40 | 0.200 |
Why?
|
| Transplantation, Isogeneic | 11 | 2001 | 248 | 0.200 |
Why?
|
| Choline | 2 | 2015 | 515 | 0.200 |
Why?
|
| Mice, Inbred NOD | 11 | 2017 | 1827 | 0.200 |
Why?
|
| Binding, Competitive | 22 | 2014 | 1141 | 0.200 |
Why?
|
| Brain Death | 2 | 2018 | 357 | 0.200 |
Why?
|
| Cell Line | 31 | 2017 | 15601 | 0.200 |
Why?
|
| Antigens, Differentiation | 7 | 2007 | 910 | 0.190 |
Why?
|
| Glucose Tolerance Test | 2 | 2017 | 1178 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 14 | 2008 | 4580 | 0.190 |
Why?
|
| Research | 3 | 2017 | 1982 | 0.190 |
Why?
|
| Biopsy | 12 | 2021 | 6766 | 0.190 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 8 | 2010 | 629 | 0.190 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2016 | 445 | 0.190 |
Why?
|
| DNA Primers | 9 | 2013 | 2819 | 0.190 |
Why?
|
| Gene Expression | 22 | 2017 | 7581 | 0.190 |
Why?
|
| Paramyxoviridae | 1 | 2020 | 9 | 0.190 |
Why?
|
| Rats | 41 | 2019 | 23742 | 0.190 |
Why?
|
| Interferon Type I | 3 | 2021 | 562 | 0.180 |
Why?
|
| Protein Biosynthesis | 10 | 2013 | 2113 | 0.180 |
Why?
|
| Kidney Glomerulus | 3 | 2018 | 568 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 18 | 2012 | 6075 | 0.180 |
Why?
|
| Leuprolide | 2 | 2014 | 312 | 0.180 |
Why?
|
| Immunosorbent Techniques | 12 | 2002 | 175 | 0.180 |
Why?
|
| Colony-Forming Units Assay | 13 | 2006 | 352 | 0.180 |
Why?
|
| Proteinuria | 3 | 2021 | 607 | 0.180 |
Why?
|
| Paramyxoviridae Infections | 1 | 2020 | 57 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 11 | 2002 | 1802 | 0.180 |
Why?
|
| Complement System Proteins | 17 | 2010 | 736 | 0.180 |
Why?
|
| Amino Acid Sequence | 32 | 2015 | 13446 | 0.180 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 100 | 0.180 |
Why?
|
| Immunological Synapses | 1 | 2020 | 59 | 0.170 |
Why?
|
| Multiple Myeloma | 9 | 2019 | 5146 | 0.170 |
Why?
|
| Immunization, Secondary | 1 | 2002 | 367 | 0.170 |
Why?
|
| Gene Expression Regulation | 10 | 2018 | 11903 | 0.170 |
Why?
|
| Hemangioblasts | 1 | 2019 | 28 | 0.170 |
Why?
|
| Coronary Vessels | 9 | 2017 | 3096 | 0.170 |
Why?
|
| Hybrid Cells | 6 | 1997 | 422 | 0.170 |
Why?
|
| Host Specificity | 1 | 2019 | 57 | 0.170 |
Why?
|
| Methylprednisolone | 2 | 1999 | 385 | 0.170 |
Why?
|
| Epidermis | 4 | 2013 | 528 | 0.170 |
Why?
|
| Clonal Deletion | 3 | 2011 | 74 | 0.170 |
Why?
|
| Cell Transformation, Viral | 1 | 2001 | 526 | 0.170 |
Why?
|
| Disseminated Intravascular Coagulation | 5 | 2004 | 186 | 0.160 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2001 | 213 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 19 | 2017 | 3810 | 0.160 |
Why?
|
| Clone Cells | 17 | 2001 | 1659 | 0.160 |
Why?
|
| Growth Substances | 2 | 1999 | 768 | 0.160 |
Why?
|
| Blood Glucose | 6 | 2017 | 6391 | 0.160 |
Why?
|
| Hypersensitivity, Delayed | 6 | 2012 | 490 | 0.160 |
Why?
|
| Membrane Glycoproteins | 10 | 2018 | 3702 | 0.160 |
Why?
|
| Hybridomas | 9 | 2002 | 442 | 0.160 |
Why?
|
| Female | 110 | 2019 | 392644 | 0.160 |
Why?
|
| Creatinine | 8 | 2012 | 1899 | 0.160 |
Why?
|
| Polymorphism, Genetic | 10 | 2001 | 4243 | 0.160 |
Why?
|
| Galactose | 3 | 2006 | 297 | 0.160 |
Why?
|
| Lung | 13 | 2021 | 10000 | 0.160 |
Why?
|
| Immunoglobulin Allotypes | 6 | 1989 | 52 | 0.150 |
Why?
|
| Combined Modality Therapy | 9 | 2014 | 8529 | 0.150 |
Why?
|
| Sialic Acids | 2 | 2017 | 123 | 0.150 |
Why?
|
| Mice, Inbred DBA | 18 | 1989 | 621 | 0.150 |
Why?
|
| Varicellovirus | 2 | 2008 | 7 | 0.150 |
Why?
|
| Plasma | 3 | 1998 | 586 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2022 | 1860 | 0.150 |
Why?
|
| Heart Failure | 1 | 2022 | 11669 | 0.150 |
Why?
|
| Blood Donors | 3 | 2016 | 345 | 0.150 |
Why?
|
| Thrombocytopenia | 6 | 2016 | 1181 | 0.150 |
Why?
|
| Rejuvenation | 2 | 2016 | 107 | 0.150 |
Why?
|
| Retroviridae Infections | 1 | 2018 | 147 | 0.150 |
Why?
|
| Endothelium, Vascular | 5 | 2002 | 4431 | 0.150 |
Why?
|
| Postoperative Complications | 14 | 2019 | 15631 | 0.150 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2017 | 373 | 0.140 |
Why?
|
| Excitation Contraction Coupling | 1 | 2017 | 25 | 0.140 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2017 | 63 | 0.140 |
Why?
|
| Staphylococcus | 8 | 1978 | 154 | 0.140 |
Why?
|
| Cell Differentiation | 14 | 2022 | 11528 | 0.140 |
Why?
|
| Liver Regeneration | 1 | 2018 | 213 | 0.140 |
Why?
|
| Evolution, Molecular | 2 | 2017 | 1886 | 0.140 |
Why?
|
| Immunoglobulin Heavy Chains | 6 | 1989 | 647 | 0.140 |
Why?
|
| Bioethics | 1 | 1998 | 117 | 0.140 |
Why?
|
| DNA, Viral | 9 | 2018 | 2202 | 0.140 |
Why?
|
| Liver Failure | 1 | 2018 | 250 | 0.140 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 1999 | 293 | 0.130 |
Why?
|
| Dogs | 8 | 2019 | 3839 | 0.130 |
Why?
|
| RNA, Viral | 8 | 2017 | 2846 | 0.130 |
Why?
|
| Cross Protection | 1 | 2016 | 25 | 0.130 |
Why?
|
| Serum Albumin, Bovine | 4 | 2003 | 321 | 0.130 |
Why?
|
| Leukocyte Count | 10 | 2012 | 1596 | 0.130 |
Why?
|
| Pluripotent Stem Cells | 2 | 2022 | 799 | 0.130 |
Why?
|
| Haplorhini | 5 | 2008 | 525 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2016 | 74 | 0.130 |
Why?
|
| West Nile virus | 1 | 2016 | 76 | 0.130 |
Why?
|
| Acute-Phase Reaction | 1 | 2015 | 91 | 0.130 |
Why?
|
| Paracrine Communication | 1 | 2017 | 277 | 0.130 |
Why?
|
| B-Cell Activating Factor | 1 | 2015 | 115 | 0.130 |
Why?
|
| Immunoglobulin Fc Fragments | 7 | 1979 | 280 | 0.120 |
Why?
|
| Measles virus | 1 | 2015 | 67 | 0.120 |
Why?
|
| Aging | 6 | 2024 | 8708 | 0.120 |
Why?
|
| Liver Failure, Acute | 1 | 2017 | 181 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2014 | 1126 | 0.120 |
Why?
|
| Blood Transfusion | 4 | 2014 | 1298 | 0.120 |
Why?
|
| Acute Disease | 15 | 2015 | 7237 | 0.120 |
Why?
|
| Lymphatic Irradiation | 1 | 2015 | 115 | 0.120 |
Why?
|
| Random Allocation | 2 | 2017 | 2395 | 0.120 |
Why?
|
| Congresses as Topic | 2 | 2017 | 803 | 0.120 |
Why?
|
| Immediate-Early Proteins | 1 | 2018 | 449 | 0.120 |
Why?
|
| Molecular Probes | 2 | 2015 | 309 | 0.120 |
Why?
|
| Biological Dressings | 1 | 2014 | 30 | 0.120 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 212 | 0.120 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 794 | 0.120 |
Why?
|
| Chemokine CXCL12 | 2 | 2015 | 454 | 0.120 |
Why?
|
| Macrophages | 10 | 2019 | 5769 | 0.120 |
Why?
|
| Rhabdoviridae Infections | 1 | 2014 | 9 | 0.120 |
Why?
|
| Stem Cell Transplantation | 5 | 2011 | 1600 | 0.120 |
Why?
|
| Coronary Disease | 5 | 2004 | 5914 | 0.120 |
Why?
|
| Transplantation, Heterotopic | 6 | 2018 | 174 | 0.120 |
Why?
|
| Antigen Presentation | 5 | 2002 | 1251 | 0.120 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2015 | 97 | 0.120 |
Why?
|
| Alphavirus Infections | 1 | 2014 | 20 | 0.120 |
Why?
|
| Immunophenotyping | 6 | 2019 | 1870 | 0.120 |
Why?
|
| Inbreeding | 4 | 2009 | 48 | 0.120 |
Why?
|
| DNA, Recombinant | 2 | 1999 | 455 | 0.110 |
Why?
|
| Plasma Exchange | 1 | 2015 | 158 | 0.110 |
Why?
|
| Pregnancy, Animal | 1 | 2014 | 124 | 0.110 |
Why?
|
| Influenza, Human | 2 | 2016 | 1521 | 0.110 |
Why?
|
| Minor Histocompatibility Loci | 4 | 2001 | 16 | 0.110 |
Why?
|
| Antigens, CD19 | 1 | 2017 | 424 | 0.110 |
Why?
|
| Animals, Inbred Strains | 5 | 2012 | 13 | 0.110 |
Why?
|
| Mice, Nude | 9 | 2015 | 3615 | 0.110 |
Why?
|
| RNA Interference | 4 | 2015 | 2831 | 0.110 |
Why?
|
| Receptors, Virus | 1 | 2017 | 640 | 0.110 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2016 | 379 | 0.110 |
Why?
|
| Immune Evasion | 1 | 2017 | 363 | 0.110 |
Why?
|
| Organ Preservation | 1 | 2017 | 382 | 0.110 |
Why?
|
| Ischemia | 2 | 2018 | 1882 | 0.110 |
Why?
|
| Regenerative Medicine | 1 | 2017 | 306 | 0.110 |
Why?
|
| Pancreas | 3 | 2000 | 1691 | 0.110 |
Why?
|
| MicroRNAs | 4 | 2018 | 3816 | 0.110 |
Why?
|
| Amino Acids | 5 | 2018 | 1718 | 0.110 |
Why?
|
| Alginates | 1 | 2015 | 248 | 0.110 |
Why?
|
| Azathioprine | 2 | 2013 | 354 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 14 | 1998 | 1741 | 0.110 |
Why?
|
| Antiviral Agents | 2 | 2017 | 3060 | 0.110 |
Why?
|
| Treatment Outcome | 18 | 2021 | 64680 | 0.110 |
Why?
|
| Cloning, Organism | 1 | 2013 | 50 | 0.110 |
Why?
|
| Myocardium | 9 | 2016 | 4726 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 699 | 0.110 |
Why?
|
| Adaptation, Physiological | 2 | 1997 | 1301 | 0.110 |
Why?
|
| Fibroblasts | 9 | 2019 | 4141 | 0.110 |
Why?
|
| Drug Therapy, Combination | 7 | 2015 | 6310 | 0.110 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 147 | 0.110 |
Why?
|
| Immunohistochemistry | 7 | 2017 | 11076 | 0.100 |
Why?
|
| Bone Marrow Purging | 2 | 2011 | 108 | 0.100 |
Why?
|
| Mutation | 12 | 2020 | 30052 | 0.100 |
Why?
|
| Antigens, Ly | 3 | 1990 | 295 | 0.100 |
Why?
|
| Animals, Laboratory | 1 | 2012 | 46 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 3602 | 0.100 |
Why?
|
| Myocytes, Cardiac | 2 | 2022 | 1668 | 0.100 |
Why?
|
| Ribavirin | 1 | 2014 | 395 | 0.100 |
Why?
|
| Cyclophosphamide | 6 | 2008 | 2218 | 0.100 |
Why?
|
| Immunocompetence | 4 | 1994 | 138 | 0.100 |
Why?
|
| Genetic Code | 6 | 1985 | 138 | 0.100 |
Why?
|
| Somatosensory Disorders | 1 | 2012 | 49 | 0.100 |
Why?
|
| HEK293 Cells | 6 | 2017 | 4278 | 0.100 |
Why?
|
| Antibodies, Bacterial | 6 | 1981 | 1469 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.100 |
Why?
|
| Leukocyte Transfusion | 5 | 2003 | 56 | 0.100 |
Why?
|
| Immunoglobulin Variable Region | 4 | 1997 | 419 | 0.100 |
Why?
|
| Telemedicine | 2 | 2020 | 3051 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 12 | 2004 | 2469 | 0.100 |
Why?
|
| Organ Specificity | 4 | 2021 | 1967 | 0.100 |
Why?
|
| Chemical Precipitation | 9 | 1982 | 175 | 0.100 |
Why?
|
| Myocardial Contraction | 1 | 2017 | 1515 | 0.100 |
Why?
|
| Fetus | 7 | 2007 | 1863 | 0.100 |
Why?
|
| Viruses | 1 | 2015 | 375 | 0.100 |
Why?
|
| Cell Adhesion | 9 | 2002 | 3087 | 0.100 |
Why?
|
| Alleles | 12 | 2009 | 6863 | 0.100 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 1626 | 0.100 |
Why?
|
| Mice, Inbred AKR | 10 | 1987 | 104 | 0.100 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 2001 | 94 | 0.100 |
Why?
|
| Capillary Leak Syndrome | 1 | 2011 | 34 | 0.100 |
Why?
|
| Interferon-gamma | 8 | 2016 | 3162 | 0.100 |
Why?
|
| Blotting, Southern | 8 | 2004 | 777 | 0.090 |
Why?
|
| Mutagenesis | 2 | 2013 | 1232 | 0.090 |
Why?
|
| Immunity | 4 | 1992 | 996 | 0.090 |
Why?
|
| Thrombosis | 7 | 2008 | 2942 | 0.090 |
Why?
|
| Virus Activation | 2 | 2004 | 322 | 0.090 |
Why?
|
| Molecular Weight | 11 | 1998 | 2186 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2017 | 1493 | 0.090 |
Why?
|
| Antigens, Viral | 1 | 2015 | 988 | 0.090 |
Why?
|
| Cell Division | 9 | 2003 | 4465 | 0.090 |
Why?
|
| Endothelium | 5 | 2008 | 765 | 0.090 |
Why?
|
| Cardiac Myosins | 1 | 2011 | 128 | 0.090 |
Why?
|
| Hematologic Diseases | 2 | 2012 | 496 | 0.090 |
Why?
|
| Boronic Acids | 1 | 2015 | 915 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1616 | 0.090 |
Why?
|
| Periodicals as Topic | 2 | 2013 | 1463 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 415 | 0.090 |
Why?
|
| Cell Proliferation | 6 | 2017 | 10445 | 0.090 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 270 | 0.090 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2011 | 186 | 0.090 |
Why?
|
| Cell Line, Tumor | 8 | 2017 | 16981 | 0.090 |
Why?
|
| DNA | 13 | 2017 | 7212 | 0.090 |
Why?
|
| Pedigree | 6 | 2009 | 4542 | 0.090 |
Why?
|
| Interferon-alpha | 1 | 2014 | 921 | 0.090 |
Why?
|
| Stromal Cells | 5 | 2006 | 1330 | 0.090 |
Why?
|
| Oligosaccharides | 2 | 2002 | 406 | 0.090 |
Why?
|
| Hepatocytes | 1 | 2017 | 1233 | 0.090 |
Why?
|
| Galactosides | 2 | 2000 | 54 | 0.090 |
Why?
|
| Sheep | 4 | 2011 | 1440 | 0.090 |
Why?
|
| Dose-Response Relationship, Immunologic | 6 | 1999 | 364 | 0.080 |
Why?
|
| Subrenal Capsule Assay | 1 | 2009 | 27 | 0.080 |
Why?
|
| Plasmapheresis | 2 | 2000 | 206 | 0.080 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 4 | 1990 | 974 | 0.080 |
Why?
|
| Microcirculation | 4 | 2008 | 1273 | 0.080 |
Why?
|
| Homozygote | 5 | 2009 | 1776 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 2 | 2013 | 940 | 0.080 |
Why?
|
| Bacterial Proteins | 3 | 2001 | 3847 | 0.080 |
Why?
|
| Nephrectomy | 2 | 2012 | 937 | 0.080 |
Why?
|
| Taxoids | 1 | 2013 | 668 | 0.080 |
Why?
|
| Glycosylation | 4 | 2013 | 1098 | 0.080 |
Why?
|
| Cloning, Molecular | 11 | 2002 | 4174 | 0.080 |
Why?
|
| Transduction, Genetic | 8 | 2003 | 903 | 0.080 |
Why?
|
| Immunization, Passive | 5 | 2003 | 616 | 0.080 |
Why?
|
| Antibody-Producing Cells | 4 | 1985 | 140 | 0.080 |
Why?
|
| Hospitals, General | 2 | 2017 | 798 | 0.080 |
Why?
|
| Facial Transplantation | 1 | 2012 | 221 | 0.080 |
Why?
|
| Umbilical Cord | 1 | 2010 | 177 | 0.080 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2009 | 686 | 0.080 |
Why?
|
| Pyrazines | 1 | 2015 | 1201 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 14666 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2014 | 1187 | 0.080 |
Why?
|
| Phagocytosis | 3 | 2019 | 1528 | 0.080 |
Why?
|
| Lectins | 2 | 2001 | 491 | 0.080 |
Why?
|
| Renal Circulation | 2 | 2007 | 291 | 0.080 |
Why?
|
| Langerhans Cells | 3 | 1994 | 170 | 0.080 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 1189 | 0.080 |
Why?
|
| Prednisone | 1 | 2013 | 1563 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 3 | 2001 | 1600 | 0.080 |
Why?
|
| Escherichia coli Infections | 1 | 2012 | 518 | 0.080 |
Why?
|
| Receptors, Lymphocyte Homing | 2 | 1998 | 141 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 2001 | 1058 | 0.080 |
Why?
|
| Edema | 1 | 2012 | 766 | 0.080 |
Why?
|
| Solubility | 7 | 2012 | 1091 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2018 | 2856 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 694 | 0.070 |
Why?
|
| Deoxyribonucleases | 3 | 1974 | 211 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2012 | 2919 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2001 | 257 | 0.070 |
Why?
|
| Viral Proteins | 1 | 2015 | 1804 | 0.070 |
Why?
|
| Extracorporeal Circulation | 4 | 2000 | 181 | 0.070 |
Why?
|
| Free Tissue Flaps | 1 | 2012 | 331 | 0.070 |
Why?
|
| Absorption | 10 | 1984 | 242 | 0.070 |
Why?
|
| Models, Immunological | 3 | 2000 | 513 | 0.070 |
Why?
|
| Precipitin Tests | 7 | 1998 | 814 | 0.070 |
Why?
|
| beta-Thromboglobulin | 1 | 2007 | 20 | 0.070 |
Why?
|
| Perfusion | 6 | 2011 | 1373 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1505 | 0.070 |
Why?
|
| ABO Blood-Group System | 5 | 2009 | 380 | 0.070 |
Why?
|
| Lipids | 1 | 2018 | 3341 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2008 | 164 | 0.070 |
Why?
|
| Plasma Cells | 2 | 2001 | 599 | 0.070 |
Why?
|
| L-Lactate Dehydrogenase | 4 | 2015 | 411 | 0.070 |
Why?
|
| United States | 6 | 2024 | 72334 | 0.070 |
Why?
|
| Blood Coagulation Disorders | 2 | 2000 | 350 | 0.070 |
Why?
|
| Cell Lineage | 3 | 2014 | 2555 | 0.070 |
Why?
|
| Dithioerythritol | 1 | 2006 | 8 | 0.070 |
Why?
|
| Sequence Alignment | 6 | 2002 | 2180 | 0.070 |
Why?
|
| Cell Line, Transformed | 4 | 2001 | 867 | 0.070 |
Why?
|
| Coronary Thrombosis | 2 | 2008 | 440 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1642 | 0.070 |
Why?
|
| Carbohydrate Sequence | 4 | 2017 | 411 | 0.070 |
Why?
|
| Hemorrhage | 3 | 2016 | 3424 | 0.070 |
Why?
|
| Herpesviridae Infections | 2 | 2005 | 270 | 0.070 |
Why?
|
| Granzymes | 1 | 2008 | 277 | 0.070 |
Why?
|
| Rats, Inbred F344 | 9 | 1994 | 826 | 0.070 |
Why?
|
| Rats, Inbred Lew | 9 | 1997 | 1157 | 0.070 |
Why?
|
| Surgery, Plastic | 1 | 2013 | 643 | 0.070 |
Why?
|
| Vidarabine | 1 | 2007 | 336 | 0.070 |
Why?
|
| Muscle, Skeletal | 3 | 2012 | 4948 | 0.060 |
Why?
|
| Gene Rearrangement | 1 | 2011 | 1125 | 0.060 |
Why?
|
| Goats | 9 | 1981 | 165 | 0.060 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1986 | 169 | 0.060 |
Why?
|
| Industry | 1 | 2008 | 364 | 0.060 |
Why?
|
| Integrins | 3 | 1998 | 834 | 0.060 |
Why?
|
| Neutropenia | 2 | 2008 | 885 | 0.060 |
Why?
|
| Blood Coagulation | 3 | 2001 | 1154 | 0.060 |
Why?
|
| Fetal Blood | 2 | 2007 | 1347 | 0.060 |
Why?
|
| Models, Genetic | 3 | 2013 | 3442 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2015 | 2093 | 0.060 |
Why?
|
| Omentum | 2 | 2003 | 168 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 809 | 0.060 |
Why?
|
| Femoral Vein | 2 | 2012 | 153 | 0.060 |
Why?
|
| RNA, Messenger | 8 | 2014 | 12795 | 0.060 |
Why?
|
| Macaca | 2 | 2019 | 410 | 0.060 |
Why?
|
| Boston | 3 | 2017 | 9326 | 0.060 |
Why?
|
| Cricetinae | 3 | 2021 | 2423 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3429 | 0.060 |
Why?
|
| Cell Survival | 5 | 2017 | 5791 | 0.060 |
Why?
|
| Plasmids | 5 | 2011 | 2269 | 0.060 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2007 | 305 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2014 | 1712 | 0.060 |
Why?
|
| Graft vs Leukemia Effect | 2 | 2002 | 121 | 0.060 |
Why?
|
| Ki-67 Antigen | 2 | 2017 | 629 | 0.060 |
Why?
|
| Mice, Transgenic | 9 | 2014 | 9539 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 2118 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2015 | 1909 | 0.060 |
Why?
|
| Weaning | 1 | 2005 | 103 | 0.060 |
Why?
|
| Transcription, Genetic | 13 | 2020 | 7594 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 1699 | 0.060 |
Why?
|
| Models, Biological | 12 | 2004 | 9469 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1475 | 0.060 |
Why?
|
| Genetic Complementation Test | 2 | 1986 | 554 | 0.060 |
Why?
|
| Bone Transplantation | 2 | 2001 | 929 | 0.060 |
Why?
|
| Biological Evolution | 6 | 1990 | 1071 | 0.060 |
Why?
|
| Tumor Virus Infections | 2 | 2015 | 438 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 2 | 1982 | 285 | 0.060 |
Why?
|
| Immunologic Factors | 2 | 2011 | 1589 | 0.060 |
Why?
|
| Dextrans | 3 | 2015 | 574 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2014 | 1584 | 0.060 |
Why?
|
| Coronary Circulation | 3 | 2007 | 1569 | 0.060 |
Why?
|
| DNA, Complementary | 4 | 2009 | 1991 | 0.060 |
Why?
|
| Inflammation | 3 | 2020 | 10773 | 0.060 |
Why?
|
| Chronic Disease | 8 | 2011 | 9318 | 0.060 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 39106 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2000 | 891 | 0.060 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 2001 | 317 | 0.060 |
Why?
|
| Cattle | 7 | 2003 | 3849 | 0.060 |
Why?
|
| Blood Group Incompatibility | 2 | 2004 | 135 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3575 | 0.060 |
Why?
|
| Carbon Radioisotopes | 4 | 2015 | 561 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2017 | 6240 | 0.060 |
Why?
|
| Publishing | 1 | 2010 | 833 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2008 | 697 | 0.050 |
Why?
|
| Antigens, CD1 | 2 | 2000 | 439 | 0.050 |
Why?
|
| Lymph Nodes | 6 | 2002 | 3466 | 0.050 |
Why?
|
| Tensile Strength | 1 | 2024 | 330 | 0.050 |
Why?
|
| Cell Fusion | 4 | 1989 | 294 | 0.050 |
Why?
|
| Graft vs Tumor Effect | 1 | 2003 | 68 | 0.050 |
Why?
|
| Mycophenolic Acid | 2 | 2002 | 348 | 0.050 |
Why?
|
| Glycoconjugates | 1 | 2003 | 88 | 0.050 |
Why?
|
| Platelet Count | 3 | 2004 | 781 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2003 | 252 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2001 | 800 | 0.050 |
Why?
|
| Interleukin-10 | 4 | 2012 | 1175 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 3879 | 0.050 |
Why?
|
| Skin Aging | 1 | 2024 | 141 | 0.050 |
Why?
|
| Tissue Banks | 1 | 2003 | 184 | 0.050 |
Why?
|
| Ribonucleases | 3 | 1972 | 277 | 0.050 |
Why?
|
| Genotype | 12 | 2006 | 12990 | 0.050 |
Why?
|
| Drug Administration Schedule | 4 | 2010 | 4853 | 0.050 |
Why?
|
| Glycoproteins | 5 | 2015 | 2203 | 0.050 |
Why?
|
| Heterozygote | 1 | 2009 | 2787 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2011 | 2116 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
| Blood | 3 | 2000 | 596 | 0.050 |
Why?
|
| Anastomosis, Surgical | 2 | 2012 | 983 | 0.050 |
Why?
|
| Papio anubis | 2 | 2015 | 23 | 0.050 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2001 | 54 | 0.050 |
Why?
|
| Immunoglobulin Isotypes | 2 | 1995 | 158 | 0.050 |
Why?
|
| Cell Communication | 4 | 2001 | 1657 | 0.050 |
Why?
|
| Horses | 3 | 2015 | 300 | 0.050 |
Why?
|
| Immunotherapy | 4 | 2013 | 4652 | 0.050 |
Why?
|
| Loss of Heterozygosity | 1 | 2004 | 662 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2004 | 767 | 0.050 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2001 | 71 | 0.050 |
Why?
|
| Genes, Viral | 3 | 2013 | 649 | 0.050 |
Why?
|
| Lymphocyte Count | 3 | 2017 | 778 | 0.050 |
Why?
|
| Dendritic Cells | 3 | 2007 | 2747 | 0.050 |
Why?
|
| Platelet Activation | 2 | 2007 | 645 | 0.050 |
Why?
|
| Ammonium Chloride | 1 | 2001 | 72 | 0.050 |
Why?
|
| Immunogenetics | 4 | 1976 | 62 | 0.050 |
Why?
|
| Neoplasms, Experimental | 5 | 2007 | 1229 | 0.050 |
Why?
|
| Immunosorbents | 2 | 1998 | 21 | 0.050 |
Why?
|
| Middle Aged | 24 | 2019 | 220895 | 0.050 |
Why?
|
| Troponin T | 3 | 2016 | 780 | 0.050 |
Why?
|
| Protein Binding | 6 | 2014 | 9351 | 0.050 |
Why?
|
| Regeneration | 1 | 2010 | 1511 | 0.050 |
Why?
|
| Career Choice | 1 | 2008 | 756 | 0.050 |
Why?
|
| Femoral Artery | 2 | 2012 | 826 | 0.050 |
Why?
|
| Dysplastic Nevus Syndrome | 1 | 2001 | 61 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2008 | 819 | 0.050 |
Why?
|
| Prostatic Neoplasms | 2 | 2015 | 11118 | 0.050 |
Why?
|
| Autoimmune Diseases | 3 | 2015 | 2244 | 0.050 |
Why?
|
| Thrombophilia | 1 | 2004 | 305 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1705 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2014 | 3242 | 0.050 |
Why?
|
| Guinea Pigs | 4 | 2014 | 1310 | 0.050 |
Why?
|
| Complementarity Determining Regions | 1 | 2001 | 149 | 0.050 |
Why?
|
| Radiation Tolerance | 1 | 2003 | 479 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 5 | 1985 | 510 | 0.050 |
Why?
|
| History, 17th Century | 1 | 2001 | 108 | 0.050 |
Why?
|
| Magnetite Nanoparticles | 2 | 2015 | 318 | 0.050 |
Why?
|
| Medicare | 1 | 2019 | 6770 | 0.050 |
Why?
|
| Proviruses | 3 | 2004 | 313 | 0.050 |
Why?
|
| Receptors, Immunologic | 2 | 1988 | 1410 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2003 | 488 | 0.050 |
Why?
|
| Adult | 23 | 2019 | 221177 | 0.050 |
Why?
|
| Antigens, CD20 | 1 | 2001 | 200 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 11460 | 0.040 |
Why?
|
| Capillaries | 2 | 2002 | 755 | 0.040 |
Why?
|
| Forecasting | 2 | 2017 | 2928 | 0.040 |
Why?
|
| Arm | 1 | 2003 | 589 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 10766 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 2001 | 193 | 0.040 |
Why?
|
| Reoperation | 4 | 2008 | 4303 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2013 | 3537 | 0.040 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2003 | 292 | 0.040 |
Why?
|
| Polyneuropathies | 1 | 2001 | 137 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 2002 | 331 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 3 | 1995 | 297 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2002 | 449 | 0.040 |
Why?
|
| Antigens, CD34 | 2 | 2007 | 658 | 0.040 |
Why?
|
| Ureter | 2 | 2001 | 367 | 0.040 |
Why?
|
| Monocytes | 4 | 2003 | 2570 | 0.040 |
Why?
|
| Massachusetts | 1 | 2013 | 8830 | 0.040 |
Why?
|
| Endothelial Cells | 3 | 2021 | 3548 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2017 | 1163 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2002 | 387 | 0.040 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 130 | 0.040 |
Why?
|
| Immunologic Techniques | 1 | 1999 | 212 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 2000 | 243 | 0.040 |
Why?
|
| alpha-Galactosidase | 1 | 2019 | 57 | 0.040 |
Why?
|
| Testosterone | 1 | 2010 | 2472 | 0.040 |
Why?
|
| Phenotype | 9 | 2017 | 16591 | 0.040 |
Why?
|
| Electroporation | 1 | 2001 | 255 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2017 | 13639 | 0.040 |
Why?
|
| Staphylococcus aureus | 2 | 1987 | 1458 | 0.040 |
Why?
|
| Pan troglodytes | 1 | 2019 | 223 | 0.040 |
Why?
|
| Gene Silencing | 2 | 2018 | 1509 | 0.040 |
Why?
|
| GATA2 Transcription Factor | 1 | 2019 | 158 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2024 | 1674 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2017 | 1529 | 0.040 |
Why?
|
| Ascorbic Acid | 2 | 2017 | 655 | 0.040 |
Why?
|
| Social Justice | 1 | 2003 | 478 | 0.040 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 1924 | 0.040 |
Why?
|
| Musculoskeletal System | 1 | 2001 | 188 | 0.040 |
Why?
|
| Trinitrobenzenes | 4 | 1982 | 46 | 0.040 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 2014 | 1148 | 0.040 |
Why?
|
| Blotting, Northern | 5 | 2000 | 1545 | 0.040 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1998 | 74 | 0.040 |
Why?
|
| Austria | 1 | 1999 | 207 | 0.040 |
Why?
|
| Rats, Inbred BN | 4 | 1980 | 231 | 0.040 |
Why?
|
| Phylogeny | 3 | 2019 | 2811 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2000 | 393 | 0.040 |
Why?
|
| Immunoglobulins | 6 | 1998 | 853 | 0.040 |
Why?
|
| Mice, Knockout | 5 | 2017 | 14414 | 0.040 |
Why?
|
| Peptide Fragments | 8 | 2009 | 5112 | 0.040 |
Why?
|
| Nephrosis | 1 | 2018 | 43 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2001 | 720 | 0.040 |
Why?
|
| Polyomavirus | 1 | 1999 | 234 | 0.040 |
Why?
|
| Nephrosis, Lipoid | 1 | 2018 | 45 | 0.040 |
Why?
|
| Portal Vein | 1 | 2001 | 431 | 0.040 |
Why?
|
| Microspheres | 2 | 2017 | 784 | 0.040 |
Why?
|
| Freund's Adjuvant | 1 | 2018 | 149 | 0.040 |
Why?
|
| Terminology as Topic | 3 | 2001 | 1530 | 0.040 |
Why?
|
| Peptide Mapping | 2 | 1989 | 262 | 0.040 |
Why?
|
| Listeriosis | 1 | 1979 | 149 | 0.040 |
Why?
|
| Transgenes | 2 | 2000 | 1010 | 0.040 |
Why?
|
| Pregnancy | 7 | 2015 | 29874 | 0.040 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2017 | 57 | 0.040 |
Why?
|
| Technology | 1 | 2020 | 292 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5247 | 0.040 |
Why?
|
| Societies, Medical | 3 | 2013 | 3905 | 0.040 |
Why?
|
| Fibrinolytic Agents | 2 | 2005 | 2084 | 0.040 |
Why?
|
| Hemoperfusion | 1 | 1997 | 13 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 1349 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5821 | 0.040 |
Why?
|
| Thromboembolism | 2 | 2004 | 995 | 0.040 |
Why?
|
| Hemagglutination Inhibition Tests | 3 | 1981 | 85 | 0.040 |
Why?
|
| Macaca mulatta | 3 | 2016 | 2329 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9420 | 0.040 |
Why?
|
| Safety-Based Drug Withdrawals | 1 | 2017 | 36 | 0.040 |
Why?
|
| Apoptosis | 8 | 2009 | 9486 | 0.040 |
Why?
|
| Neoplasm Transplantation | 3 | 2013 | 2016 | 0.040 |
Why?
|
| HLA-C Antigens | 1 | 1997 | 140 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 6 | 2000 | 5789 | 0.040 |
Why?
|
| Platelet Transfusion | 1 | 2000 | 297 | 0.040 |
Why?
|
| Pilot Projects | 4 | 2019 | 8631 | 0.040 |
Why?
|
| Chromatography, Gel | 5 | 1982 | 645 | 0.040 |
Why?
|
| Salvage Therapy | 2 | 2001 | 1264 | 0.040 |
Why?
|
| Adrenal Cortex | 1 | 1997 | 134 | 0.040 |
Why?
|
| Virulence | 1 | 2021 | 1303 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2019 | 586 | 0.030 |
Why?
|
| Guanidines | 4 | 1999 | 194 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2011 | 2510 | 0.030 |
Why?
|
| Extremities | 1 | 2002 | 867 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 2015 | 1972 | 0.030 |
Why?
|
| Receptors, Fc | 4 | 2001 | 535 | 0.030 |
Why?
|
| Structure-Activity Relationship | 5 | 1985 | 3076 | 0.030 |
Why?
|
| Liver | 4 | 2018 | 7529 | 0.030 |
Why?
|
| 3T3 Cells | 4 | 2000 | 1085 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6485 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2002 | 613 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 673 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 4740 | 0.030 |
Why?
|
| Bandages | 1 | 2018 | 269 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2015 | 1693 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2008 | 1922 | 0.030 |
Why?
|
| Insulin | 5 | 2009 | 6596 | 0.030 |
Why?
|
| Granulosa Cells | 1 | 1976 | 115 | 0.030 |
Why?
|
| Protein Conformation | 9 | 1978 | 3968 | 0.030 |
Why?
|
| Vaccinia virus | 2 | 2015 | 331 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2017 | 246 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2018 | 704 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 1974 | 201 | 0.030 |
Why?
|
| Polyglycolic Acid | 1 | 2017 | 406 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2017 | 238 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 368 | 0.030 |
Why?
|
| Collagen | 1 | 2024 | 2638 | 0.030 |
Why?
|
| Chemokines | 1 | 2020 | 960 | 0.030 |
Why?
|
| Hemagglutination Tests | 4 | 1981 | 76 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2002 | 2748 | 0.030 |
Why?
|
| Genes, Immunoglobulin | 3 | 1997 | 285 | 0.030 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2002 | 612 | 0.030 |
Why?
|
| Viral Load | 3 | 2014 | 3332 | 0.030 |
Why?
|
| Tunica Intima | 1 | 1998 | 459 | 0.030 |
Why?
|
| Concanavalin A | 4 | 1997 | 190 | 0.030 |
Why?
|
| Survival Analysis | 6 | 2003 | 10090 | 0.030 |
Why?
|
| Inverted Repeat Sequences | 1 | 2015 | 60 | 0.030 |
Why?
|
| Luciferases | 1 | 2017 | 714 | 0.030 |
Why?
|
| Cadaver | 1 | 2000 | 1358 | 0.030 |
Why?
|
| Genomics | 1 | 2011 | 5821 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2001 | 783 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2018 | 439 | 0.030 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2015 | 25 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2020 | 80636 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 5 | 1996 | 783 | 0.030 |
Why?
|
| Epitope Mapping | 2 | 2012 | 298 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2015 | 105 | 0.030 |
Why?
|
| Streptozocin | 1 | 2015 | 194 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2018 | 557 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2015 | 145 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 3 | 2002 | 283 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2015 | 150 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4575 | 0.030 |
Why?
|
| Antigenic Variation | 1 | 2015 | 118 | 0.030 |
Why?
|
| Histidine | 3 | 1972 | 308 | 0.030 |
Why?
|
| Imagination | 1 | 1976 | 226 | 0.030 |
Why?
|
| Wound Infection | 1 | 2017 | 246 | 0.030 |
Why?
|
| Ovarian Follicle | 1 | 1976 | 244 | 0.030 |
Why?
|
| Simian virus 40 | 2 | 1996 | 291 | 0.030 |
Why?
|
| Aorta | 1 | 2002 | 2042 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2015 | 224 | 0.030 |
Why?
|
| Kinetics | 6 | 2001 | 6374 | 0.030 |
Why?
|
| Disease Progression | 4 | 2017 | 13506 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 1974 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 1756 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2000 | 907 | 0.030 |
Why?
|
| Vesiculovirus | 1 | 2014 | 55 | 0.030 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2014 | 56 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2016 | 405 | 0.030 |
Why?
|
| Ferrets | 1 | 2014 | 177 | 0.030 |
Why?
|
| Viral Envelope Proteins | 1 | 2018 | 640 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2017 | 695 | 0.030 |
Why?
|
| Muscles | 2 | 2015 | 1576 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1797 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 2015 | 255 | 0.030 |
Why?
|
| Rodentia | 1 | 1995 | 262 | 0.030 |
Why?
|
| Blood Cells | 2 | 2000 | 305 | 0.030 |
Why?
|
| Community Health Services | 1 | 2019 | 656 | 0.030 |
Why?
|
| Dengue Virus | 1 | 2016 | 201 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1687 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1998 | 1202 | 0.030 |
Why?
|
| Cell Fractionation | 2 | 1998 | 251 | 0.030 |
Why?
|
| Advisory Committees | 1 | 1998 | 787 | 0.030 |
Why?
|
| Hematopoietic System | 1 | 1994 | 110 | 0.030 |
Why?
|
| Rats, Inbred WF | 3 | 1992 | 138 | 0.030 |
Why?
|
| Blood Cell Count | 2 | 2007 | 397 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 902 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1999 | 710 | 0.030 |
Why?
|
| Hemagglutinins | 1 | 2013 | 113 | 0.030 |
Why?
|
| Government Regulation | 1 | 1998 | 524 | 0.030 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2014 | 132 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 3639 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2015 | 226 | 0.030 |
Why?
|
| Karyopherins | 1 | 2014 | 132 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 878 | 0.030 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1997 | 547 | 0.030 |
Why?
|
| Kanamycin Kinase | 3 | 2000 | 34 | 0.030 |
Why?
|
| Vero Cells | 1 | 2014 | 482 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2013 | 86 | 0.030 |
Why?
|
| Plasmacytoma | 2 | 2006 | 171 | 0.030 |
Why?
|
| Aspirin | 1 | 2005 | 3133 | 0.030 |
Why?
|
| Blood Platelets | 3 | 1999 | 2479 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2018 | 823 | 0.030 |
Why?
|
| Thyroxine | 1 | 1976 | 666 | 0.030 |
Why?
|
| Coronary Artery Disease | 2 | 2007 | 6403 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2015 | 36426 | 0.030 |
Why?
|
| HLA-D Antigens | 2 | 1995 | 129 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2017 | 1201 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2014 | 678 | 0.030 |
Why?
|
| Myeloablative Agonists | 1 | 2013 | 209 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2014 | 54425 | 0.020 |
Why?
|
| Gene Library | 2 | 1995 | 1059 | 0.020 |
Why?
|
| Chemical Phenomena | 3 | 1970 | 507 | 0.020 |
Why?
|
| Hematopoietic Cell Growth Factors | 2 | 2002 | 98 | 0.020 |
Why?
|
| Models, Psychological | 1 | 1976 | 828 | 0.020 |
Why?
|
| Survival Rate | 3 | 2017 | 12725 | 0.020 |
Why?
|
| Integrases | 1 | 2014 | 516 | 0.020 |
Why?
|
| Protein Folding | 1 | 2016 | 870 | 0.020 |
Why?
|
| Restriction Mapping | 4 | 1996 | 851 | 0.020 |
Why?
|
| Cell Membrane | 4 | 1977 | 3688 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1999 | 1374 | 0.020 |
Why?
|
| Cell Movement | 2 | 2001 | 5203 | 0.020 |
Why?
|
| Lovastatin | 1 | 1992 | 115 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 934 | 0.020 |
Why?
|
| Complement Activation | 2 | 2007 | 445 | 0.020 |
Why?
|
| Carotid Artery, Common | 1 | 2012 | 175 | 0.020 |
Why?
|
| Journal Impact Factor | 1 | 2013 | 153 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1991 | 216 | 0.020 |
Why?
|
| Aged | 8 | 2020 | 169289 | 0.020 |
Why?
|
| Hydrocortisone | 2 | 1976 | 1819 | 0.020 |
Why?
|
| Binding Sites | 8 | 1997 | 6055 | 0.020 |
Why?
|
| Simplexvirus | 2 | 1995 | 803 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2017 | 1893 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2012 | 210 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1996 | 1641 | 0.020 |
Why?
|
| Elapid Venoms | 2 | 2000 | 40 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2017 | 934 | 0.020 |
Why?
|
| Macromolecular Substances | 3 | 1986 | 1434 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2017 | 1014 | 0.020 |
Why?
|
| Complement Inactivator Proteins | 2 | 2000 | 74 | 0.020 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 52 | 0.020 |
Why?
|
| Rhabdomyolysis | 1 | 1992 | 152 | 0.020 |
Why?
|
| Lymphoma | 5 | 1983 | 1901 | 0.020 |
Why?
|
| Nisoldipine | 1 | 1990 | 4 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2014 | 5035 | 0.020 |
Why?
|
| Quality Control | 2 | 2003 | 832 | 0.020 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2011 | 123 | 0.020 |
Why?
|
| Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
| Crystallography | 1 | 1990 | 116 | 0.020 |
Why?
|
| Prognosis | 3 | 2015 | 29625 | 0.020 |
Why?
|
| Chemistry | 3 | 1972 | 347 | 0.020 |
Why?
|
| Pore Forming Cytotoxic Proteins | 2 | 2001 | 133 | 0.020 |
Why?
|
| Preoperative Care | 1 | 1999 | 2242 | 0.020 |
Why?
|
| Microscopy, Electron | 3 | 1999 | 2561 | 0.020 |
Why?
|
| Perforin | 2 | 2001 | 167 | 0.020 |
Why?
|
| Thymidine Kinase | 3 | 1996 | 286 | 0.020 |
Why?
|
| Lymphokines | 2 | 1990 | 927 | 0.020 |
Why?
|
| Societies, Scientific | 1 | 1991 | 222 | 0.020 |
Why?
|
| Hypertension, Renal | 1 | 1990 | 135 | 0.020 |
Why?
|
| Action Potentials | 1 | 2017 | 1834 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 1667 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 1998 | 1664 | 0.020 |
Why?
|
| Prednisolone | 1 | 2010 | 326 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 857 | 0.020 |
Why?
|
| Lymphoid Tissue | 2 | 1997 | 445 | 0.020 |
Why?
|
| Contrast Media | 2 | 2015 | 5311 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 1990 | 285 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1990 | 413 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1998 | 4124 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6132 | 0.020 |
Why?
|
| Aldehydes | 1 | 1970 | 170 | 0.020 |
Why?
|
| Papain | 4 | 1984 | 65 | 0.020 |
Why?
|
| Complement C4b | 1 | 2009 | 126 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2013 | 522 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 681 | 0.020 |
Why?
|
| Disease Transmission, Infectious | 1 | 2014 | 559 | 0.020 |
Why?
|
| Vascular Resistance | 2 | 2007 | 930 | 0.020 |
Why?
|
| Incidence | 4 | 2015 | 21353 | 0.020 |
Why?
|
| Ultracentrifugation | 3 | 1981 | 183 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 983 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 2192 | 0.020 |
Why?
|
| Blood Physiological Phenomena | 2 | 2002 | 53 | 0.020 |
Why?
|
| HIV | 1 | 2016 | 1582 | 0.020 |
Why?
|
| Fibrinogen | 2 | 2004 | 888 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2019 | 2986 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2009 | 251 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2015 | 23995 | 0.020 |
Why?
|
| Integrin alpha4beta1 | 2 | 1998 | 119 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 1967 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1886 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3612 | 0.020 |
Why?
|
| Neoplasms | 2 | 2017 | 22170 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2012 | 1248 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2009 | 348 | 0.020 |
Why?
|
| HLA-DP Antigens | 1 | 1987 | 25 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 499 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2008 | 221 | 0.020 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2007 | 151 | 0.020 |
Why?
|
| Anesthesia, Inhalation | 1 | 1968 | 220 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 400 | 0.020 |
Why?
|
| Oxides | 1 | 2009 | 401 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1996 | 2199 | 0.020 |
Why?
|
| Infusions, Intravenous | 2 | 2002 | 2219 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 2244 | 0.020 |
Why?
|
| Injections | 1 | 2010 | 830 | 0.020 |
Why?
|
| Ascitic Fluid | 3 | 1976 | 189 | 0.020 |
Why?
|
| Organisms, Genetically Modified | 1 | 2007 | 63 | 0.020 |
Why?
|
| Rosette Formation | 6 | 1984 | 152 | 0.020 |
Why?
|
| Complement C3a | 1 | 2007 | 66 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2014 | 1336 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2979 | 0.020 |
Why?
|
| Granulocytes | 2 | 2003 | 551 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 4511 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 3 | 2012 | 7407 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 1999 | 1613 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1989 | 882 | 0.020 |
Why?
|
| G(M1) Ganglioside | 1 | 1987 | 87 | 0.020 |
Why?
|
| Remission Induction | 2 | 2005 | 2396 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 5 | 1982 | 545 | 0.020 |
Why?
|
| Prothrombin | 1 | 2007 | 191 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4111 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 1976 | 2180 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6484 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2020 | 8481 | 0.020 |
Why?
|
| Gastrostomy | 1 | 2008 | 323 | 0.020 |
Why?
|
| Receptors, Drug | 2 | 1976 | 157 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2012 | 3208 | 0.020 |
Why?
|
| Mice, Inbred CBA | 3 | 1981 | 436 | 0.020 |
Why?
|
| Hemagglutination | 1 | 1985 | 32 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1992 | 1596 | 0.020 |
Why?
|
| Nephritis, Hereditary | 1 | 2006 | 78 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 3518 | 0.020 |
Why?
|
| Isoelectric Focusing | 3 | 1981 | 150 | 0.020 |
Why?
|
| Medicaid | 1 | 2019 | 2818 | 0.020 |
Why?
|
| Serotyping | 1 | 1986 | 325 | 0.020 |
Why?
|
| Immunocompromised Host | 2 | 2002 | 856 | 0.020 |
Why?
|
| Ileostomy | 1 | 1966 | 121 | 0.020 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 422 | 0.020 |
Why?
|
| Chromium Radioisotopes | 2 | 1975 | 34 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1982 | 7856 | 0.020 |
Why?
|
| Biological Assay | 2 | 2007 | 626 | 0.020 |
Why?
|
| History, Ancient | 1 | 2005 | 212 | 0.020 |
Why?
|
| Germ Cells | 1 | 1989 | 634 | 0.020 |
Why?
|
| Hemolytic Plaque Technique | 2 | 1981 | 60 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3270 | 0.010 |
Why?
|
| Culture Techniques | 2 | 1996 | 531 | 0.010 |
Why?
|
| Erythrocyte Aggregation | 1 | 1964 | 35 | 0.010 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1993 | 918 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2014 | 1936 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 1992 | 966 | 0.010 |
Why?
|
| Ketorolac Tromethamine | 1 | 2004 | 21 | 0.010 |
Why?
|
| Methods | 4 | 1972 | 1067 | 0.010 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 2004 | 16 | 0.010 |
Why?
|
| Genome, Human | 1 | 2017 | 4425 | 0.010 |
Why?
|
| Heart, Artificial | 1 | 1964 | 107 | 0.010 |
Why?
|
| Vascular Diseases | 2 | 2005 | 1161 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2007 | 737 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2010 | 1400 | 0.010 |
Why?
|
| Alprostadil | 1 | 2004 | 86 | 0.010 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 20098 | 0.010 |
Why?
|
| Hybridization, Genetic | 2 | 1981 | 103 | 0.010 |
Why?
|
| Gestational Age | 2 | 2005 | 3577 | 0.010 |
Why?
|
| Surface-Active Agents | 1 | 1964 | 150 | 0.010 |
Why?
|
| Immune System | 1 | 2009 | 796 | 0.010 |
Why?
|
| Blood Vessels | 2 | 1999 | 1113 | 0.010 |
Why?
|
| Necrosis | 1 | 2008 | 1611 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 166 | 0.010 |
Why?
|
| Embryo Research | 1 | 2003 | 38 | 0.010 |
Why?
|
| Mice, Mutant Strains | 2 | 1985 | 1749 | 0.010 |
Why?
|
| Protozoan Infections | 1 | 2003 | 38 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1999 | 6567 | 0.010 |
Why?
|
| Gangrene | 1 | 2003 | 91 | 0.010 |
Why?
|
| Hemoglobins | 2 | 2003 | 1525 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1964 | 248 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2007 | 815 | 0.010 |
Why?
|
| Risk Factors | 3 | 2006 | 74206 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15266 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 2009 | 2645 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1983 | 76 | 0.010 |
Why?
|
| Bone and Bones | 2 | 2004 | 2568 | 0.010 |
Why?
|
| Chickens | 3 | 1998 | 859 | 0.010 |
Why?
|
| Surgically-Created Structures | 1 | 2002 | 9 | 0.010 |
Why?
|
| Echocardiography | 1 | 2016 | 4989 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1982 | 862 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2013 | 2651 | 0.010 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2003 | 113 | 0.010 |
Why?
|
| Beta-Globulins | 1 | 1982 | 27 | 0.010 |
Why?
|
| Anesthetics | 1 | 1968 | 523 | 0.010 |
Why?
|
| Antithrombins | 1 | 2005 | 294 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 2518 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 2003 | 211 | 0.010 |
Why?
|
| Ligation | 1 | 2003 | 448 | 0.010 |
Why?
|
| Hypothermia | 1 | 1964 | 188 | 0.010 |
Why?
|
| Wasting Syndrome | 1 | 2003 | 99 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 2002 | 45 | 0.010 |
Why?
|
| Medicine | 1 | 2010 | 942 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 2002 | 98 | 0.010 |
Why?
|
| RNA, Nuclear | 1 | 2002 | 30 | 0.010 |
Why?
|
| Hematocrit | 1 | 2003 | 623 | 0.010 |
Why?
|
| Haptens | 2 | 1988 | 163 | 0.010 |
Why?
|
| Latex | 1 | 2001 | 49 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1992 | 1469 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3849 | 0.010 |
Why?
|
| Multipotent Stem Cells | 1 | 2003 | 200 | 0.010 |
Why?
|
| Iodoacetamide | 1 | 1981 | 33 | 0.010 |
Why?
|
| Age Factors | 3 | 1998 | 18395 | 0.010 |
Why?
|
| Cortisone | 1 | 1982 | 87 | 0.010 |
Why?
|
| Ricin | 1 | 2001 | 70 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2005 | 771 | 0.010 |
Why?
|
| Nitrobenzenes | 1 | 1981 | 66 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1982 | 329 | 0.010 |
Why?
|
| Cell Death | 1 | 2007 | 1678 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 779 | 0.010 |
Why?
|
| Thiotepa | 1 | 1961 | 66 | 0.010 |
Why?
|
| Aspergillosis | 1 | 2003 | 242 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5439 | 0.010 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2003 | 238 | 0.010 |
Why?
|
| Uterus | 1 | 2005 | 649 | 0.010 |
Why?
|
| Oxygen | 2 | 1964 | 4227 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2010 | 2161 | 0.010 |
Why?
|
| Mesentery | 1 | 2001 | 202 | 0.010 |
Why?
|
| HIV Infections | 1 | 2007 | 17351 | 0.010 |
Why?
|
| Cladribine | 1 | 2000 | 34 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1405 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2001 | 216 | 0.010 |
Why?
|
| Crossing Over, Genetic | 3 | 1975 | 92 | 0.010 |
Why?
|
| Iron | 1 | 2009 | 1793 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3778 | 0.010 |
Why?
|
| Antigens, Bacterial | 2 | 1978 | 1155 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2003 | 516 | 0.010 |
Why?
|
| Interphase | 1 | 2001 | 228 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 4352 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 2001 | 277 | 0.010 |
Why?
|
| Mediastinum | 1 | 2001 | 267 | 0.010 |
Why?
|
| Anemia | 1 | 2009 | 1509 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8654 | 0.010 |
Why?
|
| Tetracycline | 1 | 2000 | 216 | 0.010 |
Why?
|
| Receptors, CCR5 | 1 | 2002 | 486 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2005 | 1682 | 0.010 |
Why?
|
| Neuraminidase | 1 | 1980 | 196 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2019 | 12128 | 0.010 |
Why?
|
| Disease-Free Survival | 2 | 2001 | 6814 | 0.010 |
Why?
|
| Ligands | 2 | 2000 | 3272 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2003 | 727 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 2088 | 0.010 |
Why?
|
| K562 Cells | 1 | 2001 | 642 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 1646 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 1961 | 0.010 |
Why?
|
| Clonal Anergy | 1 | 2000 | 170 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 2005 | 913 | 0.010 |
Why?
|
| C-Peptide | 1 | 2001 | 440 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1966 | 1468 | 0.010 |
Why?
|
| Registries | 1 | 2015 | 8224 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 1979 | 72 | 0.010 |
Why?
|
| Public Policy | 1 | 2003 | 559 | 0.010 |
Why?
|
| Young Adult | 2 | 2017 | 59243 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1055 | 0.010 |
Why?
|
| Fluorescence | 1 | 2001 | 756 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 14605 | 0.010 |
Why?
|
| Ureteral Diseases | 1 | 1999 | 63 | 0.010 |
Why?
|
| Ascites | 1 | 1981 | 338 | 0.010 |
Why?
|
| Cercopithecinae | 1 | 1998 | 3 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 1964 | 753 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1964 | 1173 | 0.010 |
Why?
|
| Fetal Death | 1 | 2001 | 435 | 0.010 |
Why?
|
| Leucine | 2 | 1978 | 548 | 0.010 |
Why?
|
| Integrin alpha6beta1 | 1 | 1998 | 19 | 0.010 |
Why?
|
| Mink | 1 | 1998 | 31 | 0.010 |
Why?
|
| ADAM Proteins | 1 | 2000 | 238 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2006 | 1779 | 0.010 |
Why?
|
| HIV-1 | 1 | 1996 | 6863 | 0.010 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1999 | 153 | 0.010 |
Why?
|
| Oncorhynchus mykiss | 1 | 1998 | 20 | 0.010 |
Why?
|
| Superantigens | 1 | 1998 | 127 | 0.010 |
Why?
|
| Laparotomy | 1 | 2001 | 457 | 0.010 |
Why?
|
| I Blood-Group System | 1 | 1978 | 8 | 0.010 |
Why?
|
| Doxycycline | 1 | 2000 | 344 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2003 | 803 | 0.010 |
Why?
|
| Internet | 1 | 2010 | 3092 | 0.010 |
Why?
|
| Zidovudine | 1 | 2000 | 624 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 1998 | 87 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2007 | 1171 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2003 | 1334 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 1998 | 113 | 0.010 |
Why?
|
| Germ-Free Life | 1 | 1998 | 189 | 0.010 |
Why?
|
| Journalism, Medical | 1 | 1998 | 73 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 1900 | 0.010 |
Why?
|
| X Chromosome | 1 | 1981 | 816 | 0.010 |
Why?
|
| Proteins | 2 | 2009 | 6032 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 1675 | 0.010 |
Why?
|
| Sepharose | 1 | 1998 | 103 | 0.010 |
Why?
|
| Enteritis | 1 | 1999 | 162 | 0.010 |
Why?
|
| Nephritis, Interstitial | 1 | 1999 | 155 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 2048 | 0.010 |
Why?
|
| Liposomes | 1 | 2001 | 784 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 837 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2005 | 1265 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2002 | 1813 | 0.010 |
Why?
|
| Multigene Family | 1 | 2001 | 1076 | 0.010 |
Why?
|
| Biotinylation | 1 | 1998 | 184 | 0.010 |
Why?
|
| Mathematics | 3 | 1975 | 707 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 2113 | 0.010 |
Why?
|
| Poliomyelitis | 1 | 1958 | 92 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 1998 | 332 | 0.010 |
Why?
|
| Methanol | 3 | 1972 | 92 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1997 | 283 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 3267 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2003 | 1206 | 0.010 |
Why?
|
| Virus Diseases | 1 | 2003 | 718 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2001 | 828 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2001 | 664 | 0.010 |
Why?
|
| Atrophy | 1 | 2002 | 1633 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2002 | 858 | 0.010 |
Why?
|
| Paresis | 1 | 1958 | 176 | 0.010 |
Why?
|
| Cats | 1 | 1998 | 975 | 0.010 |
Why?
|
| Laminin | 1 | 1998 | 408 | 0.010 |
Why?
|
| Longevity | 1 | 1984 | 1065 | 0.010 |
Why?
|
| Electrophoresis, Disc | 2 | 1974 | 66 | 0.010 |
Why?
|
| Reinforcement, Social | 1 | 1976 | 10 | 0.010 |
Why?
|
| Immunoglobulin D | 2 | 1992 | 54 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1998 | 310 | 0.010 |
Why?
|
| Immunodiffusion | 2 | 1974 | 141 | 0.010 |
Why?
|
| Polylysine | 1 | 1977 | 131 | 0.010 |
Why?
|
| Social Facilitation | 1 | 1976 | 31 | 0.010 |
Why?
|
| Mammals | 1 | 2002 | 1132 | 0.010 |
Why?
|
| Pancytopenia | 1 | 1997 | 102 | 0.010 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1998 | 422 | 0.010 |
Why?
|
| Heparin | 1 | 2004 | 1634 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2003 | 973 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2002 | 1078 | 0.010 |
Why?
|
| Endocarditis | 1 | 2000 | 348 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1998 | 342 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1787 | 0.010 |
Why?
|
| Infection Control | 1 | 2003 | 981 | 0.010 |
Why?
|
| Cell Count | 2 | 1994 | 1835 | 0.010 |
Why?
|
| Immunoelectrophoresis | 2 | 1972 | 94 | 0.010 |
Why?
|
| Family | 1 | 2007 | 3194 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1998 | 691 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 225 | 0.010 |
Why?
|
| Neutrophils | 1 | 2008 | 3767 | 0.010 |
Why?
|
| Models, Chemical | 3 | 1972 | 611 | 0.010 |
Why?
|
| Sarcoma Viruses, Murine | 1 | 1995 | 17 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1975 | 116 | 0.010 |
Why?
|
| Macrophages, Alveolar | 1 | 1998 | 412 | 0.010 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1997 | 242 | 0.010 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1995 | 66 | 0.010 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 1994 | 64 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1998 | 838 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 1958 | 412 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2000 | 2065 | 0.010 |
Why?
|
| Fibrosis | 1 | 2002 | 2049 | 0.010 |
Why?
|
| Morbidity | 1 | 2000 | 1750 | 0.010 |
Why?
|
| Living Donors | 1 | 1999 | 641 | 0.010 |
Why?
|
| Erythrocytes | 4 | 1994 | 2413 | 0.010 |
Why?
|
| Mitogens | 1 | 1975 | 230 | 0.010 |
Why?
|
| Recurrence | 1 | 2007 | 8465 | 0.010 |
Why?
|
| gamma-Globulins | 1 | 1974 | 119 | 0.010 |
Why?
|
| Progestins | 1 | 1976 | 301 | 0.010 |
Why?
|
| Writing | 1 | 1976 | 199 | 0.010 |
Why?
|
| Culture Media | 1 | 1976 | 897 | 0.010 |
Why?
|
| Exonucleases | 1 | 1974 | 44 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1903 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2001 | 1651 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1976 | 726 | 0.010 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1994 | 130 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1976 | 820 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1997 | 553 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 1997 | 732 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1996 | 435 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 1998 | 1007 | 0.010 |
Why?
|
| Methotrexate | 1 | 2000 | 1719 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2011 | 23445 | 0.010 |
Why?
|
| Acetates | 2 | 1972 | 321 | 0.010 |
Why?
|
| Surface Properties | 1 | 1976 | 1161 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1972 | 3769 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1974 | 214 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1972 | 2496 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1972 | 201 | 0.010 |
Why?
|
| Cyanogen Bromide | 2 | 1984 | 73 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2001 | 1755 | 0.010 |
Why?
|
| Exons | 2 | 1990 | 2391 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1995 | 397 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 790 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1974 | 445 | 0.010 |
Why?
|
| Drug Antagonism | 1 | 1992 | 51 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1993 | 303 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1994 | 574 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 2822 | 0.010 |
Why?
|
| Bradykinin | 1 | 1972 | 208 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2004 | 3688 | 0.010 |
Why?
|
| Complement Fixation Tests | 1 | 1971 | 68 | 0.010 |
Why?
|
| Mercaptoethanol | 1 | 1971 | 62 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 2751 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1996 | 719 | 0.010 |
Why?
|
| Glass | 1 | 1972 | 115 | 0.010 |
Why?
|
| Deuterium | 1 | 1971 | 106 | 0.010 |
Why?
|
| Half-Life | 1 | 1972 | 651 | 0.010 |
Why?
|
| Imidazoles | 3 | 1972 | 1180 | 0.010 |
Why?
|
| Models, Structural | 1 | 1971 | 340 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 1809 | 0.010 |
Why?
|
| Immunoassay | 1 | 1975 | 745 | 0.010 |
Why?
|
| Verapamil | 1 | 1992 | 242 | 0.010 |
Why?
|
| Interleukins | 1 | 1996 | 782 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2003 | 3673 | 0.010 |
Why?
|
| Silicones | 1 | 1972 | 228 | 0.010 |
Why?
|
| Gels | 1 | 1972 | 420 | 0.010 |
Why?
|
| Rheology | 1 | 1972 | 347 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1993 | 569 | 0.010 |
Why?
|
| Pneumonia | 1 | 2002 | 2143 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2003 | 41487 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1970 | 309 | 0.010 |
Why?
|
| Intestines | 1 | 1999 | 1909 | 0.010 |
Why?
|
| Erythrocyte Transfusion | 1 | 1994 | 565 | 0.010 |
Why?
|
| Simvastatin | 1 | 1992 | 346 | 0.010 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1989 | 93 | 0.010 |
Why?
|
| Trypsin | 2 | 1984 | 495 | 0.010 |
Why?
|
| DNA Probes | 1 | 1990 | 541 | 0.000 |
Why?
|
| Models, Cardiovascular | 1 | 1994 | 981 | 0.000 |
Why?
|
| Mortality | 1 | 2000 | 2901 | 0.000 |
Why?
|
| Chemistry, Physical | 1 | 1968 | 154 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1964 | 6225 | 0.000 |
Why?
|
| Brain | 2 | 1988 | 27112 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1992 | 978 | 0.000 |
Why?
|
| Partial Pressure | 1 | 1968 | 245 | 0.000 |
Why?
|
| Oils | 1 | 1968 | 56 | 0.000 |
Why?
|
| Pain | 1 | 2003 | 5073 | 0.000 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 1989 | 177 | 0.000 |
Why?
|
| Anticoagulants | 1 | 2004 | 4812 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1970 | 587 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1994 | 1866 | 0.000 |
Why?
|
| Ultrasonography, Interventional | 1 | 1996 | 1496 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 8002 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 550 | 0.000 |
Why?
|
| Lipopolysaccharides | 1 | 1995 | 2206 | 0.000 |
Why?
|
| Protons | 1 | 1972 | 1116 | 0.000 |
Why?
|
| Ovalbumin | 1 | 1988 | 677 | 0.000 |
Why?
|
| Glycosphingolipids | 1 | 1987 | 73 | 0.000 |
Why?
|
| Heart Diseases | 1 | 2000 | 2781 | 0.000 |
Why?
|
| Protein Structure, Tertiary | 1 | 1993 | 3792 | 0.000 |
Why?
|
| Ethyl Methanesulfonate | 1 | 1986 | 29 | 0.000 |
Why?
|
| Oxazolone | 1 | 1986 | 61 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1986 | 227 | 0.000 |
Why?
|
| Single-Blind Method | 1 | 1990 | 1572 | 0.000 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 5440 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 12974 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1992 | 1502 | 0.000 |
Why?
|
| Antibodies, Neoplasm | 1 | 1987 | 281 | 0.000 |
Why?
|
| Pressure | 1 | 1968 | 1154 | 0.000 |
Why?
|
| Child | 2 | 2008 | 80153 | 0.000 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 4414 | 0.000 |
Why?
|
| Antigens, Neoplasm | 1 | 1973 | 1993 | 0.000 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2000 | 5305 | 0.000 |
Why?
|
| Cryoprotective Agents | 1 | 1985 | 128 | 0.000 |
Why?
|
| Introns | 1 | 1987 | 981 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1994 | 1514 | 0.000 |
Why?
|
| Melanoma, Experimental | 1 | 1987 | 560 | 0.000 |
Why?
|
| Isotope Labeling | 2 | 1976 | 392 | 0.000 |
Why?
|
| Ilium | 1 | 1984 | 155 | 0.000 |
Why?
|
| Cytochrome c Group | 1 | 1983 | 122 | 0.000 |
Why?
|
| Phytohemagglutinins | 1 | 1983 | 167 | 0.000 |
Why?
|
| RNA | 1 | 1993 | 2726 | 0.000 |
Why?
|
| Ribs | 1 | 1984 | 252 | 0.000 |
Why?
|
| Nucleotidases | 1 | 1982 | 29 | 0.000 |
Why?
|
| Lymphocyte Cooperation | 1 | 1982 | 112 | 0.000 |
Why?
|
| Bacteriophage lambda | 1 | 1982 | 142 | 0.000 |
Why?
|
| Rana catesbeiana | 1 | 1981 | 85 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 17904 | 0.000 |
Why?
|
| Adolescent | 2 | 2003 | 88319 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 1997 | 58976 | 0.000 |
Why?
|
| Logistic Models | 1 | 1996 | 13255 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1982 | 1302 | 0.000 |
Why?
|
| Antihypertensive Agents | 1 | 1990 | 2024 | 0.000 |
Why?
|
| Azides | 1 | 1979 | 118 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2000 | 11742 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1998 | 26198 | 0.000 |
Why?
|
| Femur | 1 | 1984 | 1307 | 0.000 |
Why?
|
| Breeding | 1 | 1977 | 51 | 0.000 |
Why?
|
| Spine | 1 | 1984 | 1118 | 0.000 |
Why?
|
| Polyribonucleotides | 1 | 1976 | 5 | 0.000 |
Why?
|
| Karyotyping | 1 | 1979 | 1171 | 0.000 |
Why?
|
| Sex Chromosomes | 1 | 1977 | 101 | 0.000 |
Why?
|
| Nitrophenols | 1 | 1976 | 169 | 0.000 |
Why?
|
| Neuraminic Acids | 1 | 1974 | 16 | 0.000 |
Why?
|
| Genes, Recessive | 1 | 1977 | 623 | 0.000 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1974 | 125 | 0.000 |
Why?
|
| Infant | 1 | 1996 | 36192 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1996 | 42230 | 0.000 |
Why?
|
| Butanols | 1 | 1972 | 19 | 0.000 |
Why?
|
| Formates | 1 | 1972 | 40 | 0.000 |
Why?
|
| Chloroform | 1 | 1972 | 31 | 0.000 |
Why?
|
| Imines | 1 | 1972 | 27 | 0.000 |
Why?
|
| Carboxylic Acids | 1 | 1972 | 90 | 0.000 |
Why?
|
| Cyclohexanes | 1 | 1972 | 152 | 0.000 |
Why?
|
| X-Ray Diffraction | 1 | 1972 | 421 | 0.000 |
Why?
|
| Ions | 1 | 1972 | 256 | 0.000 |
Why?
|
| Chromatography | 1 | 1971 | 189 | 0.000 |
Why?
|
| Aspartic Acid | 1 | 1972 | 576 | 0.000 |
Why?
|
| Dipeptides | 1 | 1972 | 391 | 0.000 |
Why?
|
| Vibration | 1 | 1971 | 328 | 0.000 |
Why?
|
| Lysine | 1 | 1972 | 993 | 0.000 |
Why?
|
| Leukemia | 1 | 1971 | 1522 | 0.000 |
Why?
|